Getting the Most Out of Shorter Biotech Investor Meetings
Do you find yourself rushing to tell your whole story at conference meetings? Milestone Advisors shares some tips to sharpen your storytelling so that short meetings can lead to lasting investor interest.
Preparing Your S-1: What Life Sciences Companies Should Do as the IPO Window Begins to Open
The life sciences IPO window is beginning to open. Here’s how Milestone Advisors helps companies prepare S-1 filings that stand out and accelerate IPO readiness.
Innovative treatments are making meaningful strides against some of the largest unmet needs across medicine at the same time pharma has its greatest ever pressure to replenish pipelines with new products.
